comparemela.com
Home
Live Updates
Venetoclax Combinations Have Sustained Long-term Benefits for Relapsed, Refractory Chronic Lymphocytic Leukemia : comparemela.com
Venetoclax Combinations Have Sustained Long-term Benefits for Relapsed, Refractory Chronic Lymphocytic Leukemia
Long-term data show that venetoclax combinations benefit progression free survival and overall survival in patients with or without previous treatment for chronic lymphocytic leukemia.
Related Keywords
Melbourne
,
Victoria
,
Australia
,
Germany
,
German
,
Venclexta Venclyxto
,
Mariana Cota Stirner
,
Othman Al Sawaf
,
John Seymour
,
University Hospital Cologne
,
Peter Maccallum Cancer Center
,
Hematology Department
,
Genentech
,
Study Group
,
European Hematology Association Annual Congress
,
Integrated Hematology Department
,
Royal Melbourne Hospital
,
comparemela.com © 2020. All Rights Reserved.